Stevens-Johnson syndrome and toxic epidermal necrolysis are severe, life-threatening drug reactions involving skin and membranes mucous, which are associated with significant morbidity and mortality and triggered, especially by drug exposure. Different studies have demonstrated that drug response is a multifactorial character and that the interindividual variability in this response depends on both environmental and genetic factors. The last ones have a relevant significance. In fact, the identification of new specific genetic markers involved in the response to drugs, will be of great utility to establish a more personalized therapeutic approach and to prevent the appearance of these adverse reactions. In this review, we summarize recent progresses in the Pharmacogenetics studies related to Stevens-Johnson syndrome/toxic epidermal necrolysis reporting the major genetic factors identified in the last years as associated with the disease and highlighting the use of some of these genomic variants in the clinical practice.

Rufini, S., Ciccacci, C., Politi, C., Giardina, E., Novelli, G., Borgiani, P. (2015). Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction. PHARMACOGENOMICS [10.2217/pgs.15.128].

Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction

RUFINI, SARA;CICCACCI, CINZIA;GIARDINA, EMILIANO;NOVELLI, GIUSEPPE;BORGIANI, PAOLA
2015

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis are severe, life-threatening drug reactions involving skin and membranes mucous, which are associated with significant morbidity and mortality and triggered, especially by drug exposure. Different studies have demonstrated that drug response is a multifactorial character and that the interindividual variability in this response depends on both environmental and genetic factors. The last ones have a relevant significance. In fact, the identification of new specific genetic markers involved in the response to drugs, will be of great utility to establish a more personalized therapeutic approach and to prevent the appearance of these adverse reactions. In this review, we summarize recent progresses in the Pharmacogenetics studies related to Stevens-Johnson syndrome/toxic epidermal necrolysis reporting the major genetic factors identified in the last years as associated with the disease and highlighting the use of some of these genomic variants in the clinical practice.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/03 - Genetica Medica
English
SJS/TEN; allopurinol; carbamazepine; genomic biomarkers; nevirapine; pharmacogenetics; polymorphisms
Rufini, S., Ciccacci, C., Politi, C., Giardina, E., Novelli, G., Borgiani, P. (2015). Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction. PHARMACOGENOMICS [10.2217/pgs.15.128].
Rufini, S; Ciccacci, C; Politi, C; Giardina, E; Novelli, G; Borgiani, P
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Stevens-Johnson syndrome and toxic epidermal necrolysis an update on pharmacogenetics studies in drug-induced severe skin reaction.pdf

non disponibili

Licenza: Copyright dell'editore
Dimensione 677 kB
Formato Adobe PDF
677 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/126640
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact